Rixheim, France

Jacques Cercus

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Cercus. Retrieved from https://idiyas.com/inventor/jacques-cercus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacques Cercus: Innovator in Pharmaceutical Chemistry

Introduction

Jacques Cercus is a notable inventor based in Rixheim, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of phenylacetic acid derivatives. His work has implications for the development of various pharmaceutical compounds.

Latest Patents

Jacques Cercus holds a patent for a process related to phenylacetic acid derivatives. The patent details a method for the production of a compound of Formula I, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof. This process involves cleaving a lactam of formula II, showcasing his innovative approach to chemical synthesis.

Career Highlights

Cercus is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to apply his expertise in pharmaceutical development and contribute to the advancement of medical science. His work is characterized by a commitment to innovation and quality in drug development.

Collaborations

Jacques has collaborated with esteemed colleagues such as Murat Acemoglu and Thomas Allmendinger. These partnerships highlight the collaborative nature of research and development in the pharmaceutical industry.

Conclusion

Jacques Cercus is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug production. His contributions continue to impact the field positively, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…